Gary Foster

McMaster University

Papers

1

Total Citations

24

H-Index

1

About

Dr. Gary Foster is a leading thoracic surgeon and clinical researcher whose work focuses on advancing minimally invasive surgical techniques for lung cancer treatment. His major contributions center on comparative effectiveness research, particularly through the landmark RAVAL trial—a groundbreaking international, multi-centered, blinded, randomized controlled trial comparing robotic-assisted versus video-assisted lobectomy for early-stage lung cancer. This protocol paper, published in 2022 with 24 citations, has already shaped the evidence base for surgical decision-making. Foster’s research addresses critical outcomes including postoperative pain, mortality, length of stay, chest tube duration, and pulmonary complications, directly impacting patient recovery and quality of life. His work bridges the gap between retrospective data and rigorous prospective evidence, providing surgeons and patients with clearer guidance on surgical options. Foster’s dedication to high-quality trial design and international collaboration underscores his commitment to advancing thoracic oncology. For students and researchers, his career exemplifies how methodologically sound clinical research can translate into meaningful improvements in surgical care and patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
RAVAL trial: Protocol of an international, multi-centered, blinded, randomized controlled trial comparing robotic-assisted versus video-assisted lobectomy for early-stage lung cancer
24 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: McMaster University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago